Technology News and Research

RSS

Hospital architecture, design and sensory stimulation make rehabilitation more effective

How does the hospital environment affect our rehabilitation? New research from the University of Gothenburg, Sweden, into how the space around us affects the brain reveals that well-planned architecture, design and sensory stimulation increase patients' ability to recover both physically and mentally. Digital textiles and multisensory spaces can make rehabilitation more effective and reduce the amount of time spent in care.

2 Nov 2011

NIH-funded project to discover biomarkers for type 2 diabetes

Arizona State University will lead a four-year, $5 million expanded initiative sponsored by the National Institutes of Health to discover proteins, or biomarkers, to help predict cardiovascular disease and to assess potential new treatments in people with type 2 diabetes.

2 Nov 2011

Johns Hopkins breast cancer researcher wins BioMaryland LIFE Prize

A Johns Hopkins breast cancer researcher is the recipient of a $50,000 award designed to encourage rapid translation of her basic research on biomarkers into a commercially available test that could predict the best treatment options for some women with breast cancer.

2 Nov 2011

Innovative mobile-technology strategy to prevent HIV/AIDS in Uganda

1 million people in Uganda live with HIV/AIDS, where long distances and expensive travel costs significantly limit access to treatment. By employing an innovative mobile-technology strategy, Dr. Femida Gwadry-Sridhar, Director of I-THINK Research at Lawson Health Research Institute, hopes to provide a much-needed solution.

2 Nov 2011

Researchers develop new 3D bone marrow culture systems

Stromal cells, as distinct from hematopoietic cells, are an essential component of the bone marrow microenvironment and are necessary for the long-term maintenance of hematopoietic stem cells (HSCs) in vitro.

2 Nov 2011

SurModics to sell Pharma assets to Evonik for $30 million

SurModics, Inc., a leading provider of surface modification technologies to the healthcare industry, announced today that it has entered into a definitive agreement to sell its SurModics Pharmaceuticals assets to Evonik Industries AG for $30 million in cash.

2 Nov 2011

New protein microarray technology could eradicate malaria

A new research technology is revealing how humans develop immunity to malaria, and could assist programs aimed at eradicating this parasitic disease.

2 Nov 2011

MIT develops new software to speed up MRI scans

Magnetic resonance imaging (MRI) devices can scan the inside of the body in intricate detail, allowing clinicians to spot even the earliest signs of cancer or other abnormalities. But they can be a long and uncomfortable experience for patients, requiring them to lie still in the machine for up to 45 minutes.

2 Nov 2011

FDA approves Abbott's XIENCE PRIME Everolimus Eluting Coronary Stent System

Abbott today announced it has received U.S. Food and Drug Administration (FDA) approval for the next-generation XIENCE PRIME Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease.

2 Nov 2011

GSK, Alnylam collaborate to apply VaxiRNA technology for influenza vaccine production

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today it has formed a collaboration with GlaxoSmithKline (GSK) focused on Alnylam's VaxiRNATM technology for certain GSK vaccine products, including influenza. VaxiRNA is a new RNAi technology for the enhanced production of viruses used in the manufacture of vaccine products. GSK, a leading vaccine manufacturer, is the first company to form a collaboration accessing this new platform.

2 Nov 2011

NovaSterilis reports significant findings from sterilization of absorbable suture study

NovaSterilis Inc. a leader in the development and commercialization of supercritical carbon dioxide (SCCO2) technology in collaboration with CC Chu Ph.D (Cornell) reports successful findings from research funded by a National Institutes of Health (NIH) phase l grant. These results meet the study goal to sterilize absorbable sutures to a sterility assurance level 10-6 (SAL6) without chemical or mechanical degradation. NovaSterilis intends to apply for phase II funding to develop the process ready for commercial application.

1 Nov 2011

New e-tool to catch youth depression before it takes hold

Australian researchers will for the first time harness e-technology to develop a customised internet program to identify and arm healthy young people most at risk of depression before the illness takes hold.

1 Nov 2011

LDR's ROI-A Oblique ALIF cage receives FDA marketing clearance

LDR, a privately held medical device company offering innovative spinal implants for both non-fusion and fusion applications, announced that it has received 510(k) clearance from the United States Food and Drug Administration to market the ROI-A Oblique ALIF cage. The oblique cage complements its forerunner, the ROI-A ALIF cage, which is designed for direct anterior insertion.

1 Nov 2011

Henry Schein third quarter net sales increase 11.5% to $2.1 billion

Henry Schein, Inc., the largest provider of healthcare products and services to office-based practitioners, today reported record financial results for the quarter ended September 24, 2011.

1 Nov 2011

Senior Scientific's nanomagnetic technology more sensitive in detecting breast cancer

Manhattan Scientifics announced today that "Breast Cancer Research," an international, peer-reviewed online journal, has published results of a study using Senior Scientific's nanomagnetic technology.

1 Nov 2011

iBio receives U.S. patent entitled 'System for Expression of Genes in Plants'

iBio, Inc. today announced notice of issuance from the United States Patent and Trademark Office for US Patent 8,058,511, entitled "System for Expression of Genes in Plants," that further extends iBio's patent coverage of viral vectors comprising its iBioLaunch platform.

1 Nov 2011

Three centers to improve clinical preventive services and practices

The Agency for Healthcare Research and Quality (AHRQ) awarded three-year grants totaling $4.5 million to support research in three centers that will focus on improving clinical preventive services and practices such as screening, counseling and use of preventive medications for patients.

1 Nov 2011

FDA approves expansion of MRI use with Cyberonics' VNS Therapy System

Cyberonics, Inc., a global leader in medical devices for the treatment and management of epilepsy, today announced that the U.S. Food and Drug Administration approved a significant expansion of options for Magnetic Resonance Imaging use by patients who have the VNS Therapy System.

1 Nov 2011

Vampire-like bacteria has potential to serve as living antibiotic

A vampire-like bacteria that leeches onto specific other bacteria - including certain human pathogens - has the potential to serve as a living antibiotic for a range of infectious diseases, a new study indicates.

1 Nov 2011

Legislation introduced to offer some legal protection to providers who use electronic medical records

The legislation, which would focus its legal protection on providers who participate in Medicare and Medicaid, is designed to encourage the adoption of health information technology.

1 Nov 2011